Website intended for a NZ health professional readership
Clinical pharmacist Katrina Azer writes about pharmacogenomics, the promising field that helps tailor medications to genes. She reviews its impact on clinical practice and the challenges that need to be overcome to adopt it
1. National Institute of General Medical Sciences. Pharmacogenomics.
2. PharmGKB.
3. Swen JJ, van der Wouden CH, Manson LE, et al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet 2023;401(10374):347–56.
4. Connelly D. Pharmacogenomic testing pilot to start in general practice from June 2023. The Pharmaceutical Journal, 18 May 2023.
5. Arnone D, Omar O, Arora T, et al. Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials. Neurosci Biobehav Rev 2023;144:104965.
6. Krebs K, Milani L. Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good. Hum Genomics 2019;13(1):39.
Nataly Martini provides a brief overview of selected causes of dizziness and vertigo, such as benign paroxysmal positional vertigo and vestibular migraine. Through case studies, she explains how these conditions may differ from serious clinical syndromes such as cervicogenic dizziness, highlighting the complexities, risk factors and management of these conditions
Talking about butt stuff in the pharmacy can be awkward. Care Pharmaceuticals and Rectogesic® can help you get to the bottom of the issue
